Overview

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the biodegradation of the brimonidine tartrate posterior segment drug delivery system.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
Brimonidine Tartrate